INTERNATIONAL PATENT: IMMUTEP S.A.S. FILES APPLICATION FOR "COMBINATION THERAPY USING LAG-3 PROTEIN AND ANTI-PD-1 INHIBITOR WITH RADIOTHERAPY FOR TREATING CANCER"

GENEVA, Nov. 10 -- IMMUTEP S.A.S. (Parc Les AlgorithmesBatiment 7 - Le PythagoreRoute de l'Orme - RD12891190 Saint-Aubin) filed a patent application (PCT/EP2025/062025) for "COMBINATION THERAPY USING LAG-3 PROTEIN AND ANTI-PD-1 INHIBITOR WITH RADIOTHERAPY FOR TREATING CANCER" on May 01, 2025. With publication no. WO/2025/229157, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SOBCZUK, Pawel (Narodowy Instytut Onkologii im.Marii Skłodowskiej-Curie Państwowy Instytut Badawczy W.K. Roentgena 502-781 Warszawa), KOZA...